Small Cap Value Report (14 Feb 2017) - SXS, PEB, RWS, PDG, ALT

Tuesday, Feb 14 2017 by

Good afternoon!

I'm planning to cover a couple of today's trading updates, plus the full year results from Spectris. Feedback is very welcome as usual - especially in helping me to understand which companies are most in demand, which will influence future reports.



Spectris (LON:SXS)

Share price: 2500p (+3%)
No. shares: 119m
Market cap: £2,980m

I'll keep this brief since everything seems to be going pretty well for Spectris at the moment, after a difficult year but with an improving trend in the final quarter. Like-for-like sales finished down by 2% (they had been running at -4% prior to the final quarter).

This is a global instrumentation/controls business - giving exposure to a wide range of industrial markets.

There is currently some change afoot:

Our strategy is evolving from being the supplier of products towards the provision of complete solutions (a combination of hardware, software and services) to our customers, based on our deep application and technical expertise. As our customers focus on their core activities and seek to reduce cost and complexity, they have a greater need to outsource services to a trusted, reliable partner who is able to deliver high quality technical solutions.

Project uplift: A new project, expected to cost £45 million in one-off costs, but which will result in annualised cost savings of £35 million - a highly material amount.

Results: there was unfortunately a large impairment of goodwill, creating a discrepancy between adjusted and reported results.



Always worth investigating impairments:

The reported operating profit included a non-cash impairment charge of £115.3 million pre-tax relating to a write-down of the balance sheet goodwill and other intangibles associated with Omega Engineering ('Omega') and ESG Solutions ('ESG'). The impairment charge arose from the recent weaker trading performance due to the challenging conditions experienced, particularly in North America, and ongoing process improvement requirements at Omega and for ESG, the continued weakness in the global oil and gas markets.

Dividend: up by 5%, made possible by 113% of adjusted operating profit being converted into cash.

My opinion: 

I've always perceived this to be a very good-quality business - too large to get a good handle on without doing a lot of detailed research, but almost certainly worth considering for a diversified FTSE-250 portfolio. Diversified exposure to niche industrial services, along with a…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way


All my own views. I am not regulated by the FSA. No advice.

Do you like this Post?
69 thumbs up
2 thumbs down
Share this post with friends

Spectris plc is a supplier of productivity-enhancing instruments and controls. It operates through four segments: Materials Analysis, Test and Measurement, In-Line Instrumentation and Industrial Controls. Materials Analysis segment provides products and services that determine structure, composition, quantity and quality of particles and materials, during research and product development processes. The Test and Measurement segment supplies test, measurement and analysis equipment, software and services for product design optimization, manufacturing control, microseismic monitoring and environmental noise monitoring. The In-line Instrumentation segment provides process analytical measurement, asset monitoring and online controls, as well as associated consumables and services for primary processing and the converting industries. Industrial Controls segment provides products and solutions that measure, monitor, control and connect during the production process. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Pebble Beach Systems Group plc, formerly Vislink plc, is a software and technology company. The Company is engaged in the collection and delivery of video and data from scene to screen. The Company's Pebble Beach Systems division is a developer and supplier of automation, Channel-in-a-Box and content management software solutions for television broadcasters, cable and satellite operators. For the broadcast markets, the Company provides wireless communication solutions for the collection of live news, sport and entertainment. The Company's products include Marina, which is an enterprise level playout automation platform for multi-channel applications; Orca, which is an Internet Protocol (IP)-enabled cloud-based integrated channel delivery solution; Dolphin, which provides multi-format integrated channel delivery solutions based on information technology (IT) hardware, and Stingray, which is a self-contained Channel-in a-Box. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

RWS Holdings plc is a holding company, which provides intellectual property support services (patent translations, international patent filing solutions and searches), in life sciences translations and linguistic validation. The Company provides specialist language service in other technical areas. The Company has four operating segments: RWS Patent Translation & Filing division which provides patent translation and filing services: RWS Patent Information division which provides a range of patent search, retrieval and monitoring services as well as a comprehensive patent database service accessible; RWS Life Sciences division which provides technical translations and linguistic validation to the medical and pharmaceutical sector. This division includes the LUZ, Inc, and RWS Language Solutions division, which provide non-patent or non-life science technical translations. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

  Is LON:SXS fundamentally strong or weak? Find out More »

15 Comments on this Article show/hide all

alterego 14th Feb '17 1 of 15

RWS has issued an upbeat AGM statement, an acquisition and a placing. The shares look pricey, but they always seem to be highly rated.

| Link | Share
Gerry43 14th Feb '17 2 of 15

Any chance of taking a look at Pendragon today Graham?

| Link | Share
Ramridge 14th Feb '17 3 of 15

alterego - I had a good look at RWS Holdings (LON:RWS) this morning. I like the acquisition as it seems to be on modest multiples. However as you say, RWS's ratios suggest the shares are over-priced. I calculated that any positive impact from the acquisition would still make the shares over priced IMO.
So reluctantly I did not buy any.

| Link | Share
sharw 14th Feb '17 4 of 15

Pebble Beach Systems (LON:PEB) is worth a mention. On January 16th Paul Scott referred to "the idiot in charge (Hawkins), who has run this company into the ground". Today it has been announced that he has been given the order of the boot. Alleluia.

| Link | Share | 1 reply
Bonitabeach 14th Feb '17 5 of 15

In reply to post #171358

Be careful what you wish for - he may just have made for the exit with his payoff before the administrators walk in.


No position.

| Link | Share | 1 reply
Graham Neary 14th Feb '17 6 of 15

Thanks very much, I'm covering RWS and PEB and will also check if I can add something on PDG.

| Link | Share
bestace 14th Feb '17 7 of 15

RWS Holdings (LON:RWS) has always looked expensive, yet their revenues and profits continue to grind higher and higher each year with the share price following.

There's no arguing with the quality metrics here and they have a decent track record on acquisitions. This latest acquisition seems to fit the mould with healthy margins, they are paying what seems to be a reasonable price with dilution held to a minimum. I also like that they are diversifying away from the patents business.

I'm happy enough to continue holding for now.

| Link | Share
tabhair 14th Feb '17 8 of 15

In reply to post #171364

The most recent annual report says he is entitled to 12 months salary, which means another £360k goes out the door for a company that is already in breach on banking covenants. That is a real kick in the teeth for suffering shareholders.

| Link | Share
alterego 14th Feb '17 9 of 15

re RWS, Graham you asked if the growth was all due to the size of the market. The answer is partly yes as the number of patent applications is growing each year but there's competition for translation services from less qualified suppliers and machine based translation. My understanding is that RWS is highly regarded for its accuracy and reliability. Most of its staff are graduates and quality is paramount when dealing with large multinationals who will not tolerate sloppy work. Who do you turn to when you need a patent translated into multiple different languages for all the territories your corporation operates in? They also own and operate a searchable database of more than 47m patent families which is a pretty unrivalled source of data going back to 1990.

Andrew Brode is the driving force behind the company and owns 41% of the stock so he's clearly got a huge amount of skin in the game. I like the fact that RWS are very selective in the way they grow the business as the track record demonstrates. I'm inclined to believe the broadening into life sciences will pay off.

I've had a holding in RWS since 2010 when the SP was under 60p and although I always think the p/e might be overcooked, I've resisted the temptation to believe it.

| Link | Share
Gostevie 14th Feb '17 10 of 15

Hello Graham,

I have no personal knowledge of such things, but a friend of mine who is a recently retired Patent Attorney told me that Companies like RWS Holdings (LON:RWS) could face a threat from the new European Unitary Patent:

I stress again, no personal expertise in this subject.


| Link | Share | 1 reply
LongbeardRanger 14th Feb '17 11 of 15

In reply to post #171421

Hello Steve,

yes, this is an issue RWS have been drawing attention to for a while. You can find discussion of it in their most recent annual report. They anticipate "minimal revenue loss in FY17" and say something a bit more vague relating to 2018 and beyond. To be fair to them, I dom't think this is evasiveness - I think they genuinely don't know what the effect will be.

The acquisition of CTi last year and now LUZ this year means that, while RWS' biggest source of revenue is still patent translation, it's not as dominant a source of revenue as it once was.



| Link | Share
alterego 14th Feb '17 12 of 15

RWS and the European Unitary patent issue boils down to the desire to have a single patent which applies in multiple countries. It sounds sensible but the evidence so far is that large corporations do not want to risk a system that is untested while they have the option of individual patents they know have legal resilience. As with many things, better the devil you know.

| Link | Share | 1 reply
LongbeardRanger 14th Feb '17 13 of 15

In reply to post #171433

Yes - especially so where the cost of the individual parents are low in the context of their potential value.

I do expect the unitary patent to gain traction over time, but I don't think there will be sudden mass take up of it.

| Link | Share
jonesj 14th Feb '17 14 of 15

Purchased RWS in 2010 for £2.57.
They rose to over £8, then had a 5:1 stock split.
Current price is £3.55.
So effectively 6.9x original purchase cost.

I continue to hold, but whether I should do that at the current valuation is another question.

| Link | Share
samanddee 14th Feb '17 15 of 15

Any chance of covering Melrose Industries - not small cap but one that seems to get little attention and had a stellar year or so. Is this another one to price on PEG perhaps?

| Link | Share

Please subscribe to submit a comment

 Are LON:SXS's fundamentals sound as an investment? Find out More »

About Graham Neary

Graham Neary

Full-time investor and independent analyst. Editor at Cube.Investments, small-cap writer at Stockopedia. Previously a fixed income analyst in the City and institutional fund manager. I'm a CFA charterholder and have the Investment Management Certificate and STA Diploma in Technical Analysis for good measure. When I'm not talking about finance, I enjoy recreational poker, chess and Mandarin Chinese. more »


Stock Picking Tutorial Centre

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis